Skip to main content

NY Woman Claims ParaGard IUD Broke In Her Uterus

NY Woman Claims ParaGard IUD Broke In Her Uterus

NY Woman Claims ParaGard IUD Broke In Her Uterus

Introduction

Last Monday, a New York woman, filed a lawsuit against Teva Pharmaceuticals USA Inc. and the Cooper Companies Inc. in the state's federal court, alleging that the ParaGard intrauterine device (IUD) broke off in her uterus during removal.

According to the lawsuit, the plaintiff had the device implanted in June 2017. In September, the same year, she went to have it removed after an ultrasound showed it moved out of place. Her physician tried to remove the device following Teva's instructions, but a part of the device broke off, resulting in surgery to have the remaining part of the device removed. Johnson filed the suit claiming that she suffered a range of injuries, including loss of reproductive health, pain, suffering, mental anguish, and loss of enjoyment of life, on top of the medical bills.

The lawsuit also claims that Teva amplified the benefits of the device and knew or should have known about its defects based on trials, third-party studies, and consumer experience and complaints. The lawsuit also names the Cooper Companies and a subsidiary as defendants, as they purchased the rights to the ParaGard in September 2017.

The complaint indicated that more than 1,600 cases of the ParaGard breaking were reported to the U.S. Food and Drug Administration (FDA), out of those more than 700 were deemed serious.

The plaintiff is seeking undefined damages for 11 different counts, including negligence, common law fraud, breach of express and implied warranty, design and manufacturing defects, failure to warn, and violations of consumer protection laws.

Several lawsuits have been filed against the birth control device involving similar allegations of problems during removal surgery. The lawsuits are pending in their individual courts, and an MDL is yet to be formed.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!